Central Venous Catheter Associated Bloodstream Infection
5
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients
Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery
Artificial Intelligence With Determination of Central Venous Catheter Line Associated Infection Risk
t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection